Early impairment of coronary flow reserve in young men with borderline hypertension

Journal of the American College of Cardiology

Volumn 32, Issue 1, 1998, Pages 147-153

  Laine, Hanna ^a   Raitakari, Olli T ^a   Niinikoski, Harri ^a   Pitkänen, Olli Pekka ^a   Iida, Hidehiro ^b   Viikari, Jorma ^a   Nuutila, Pirjo ^a   Knuuti, Juhani ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b RESEARCH INSTITUTE FOR BRAIN AND BLOOD VESSELS AKITA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE;

ADULT; ARTICLE; BLOOD FLOWMETRY; BORDERLINE HYPERTENSION; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; VASODILATATION;

ADULT; BLOOD PRESSURE MONITORS; CORONARY CIRCULATION; DIPYRIDAMOLE; ELECTROCARDIOGRAPHY, AMBULATORY; HUMANS; HYPERTENSION; MALE; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED; VASCULAR RESISTANCE; VASODILATOR AGENTS; VASOMOTOR SYSTEM;

EID: 0032126325     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00222-8     Document Type: Article

References (48)

1. Dayanikli F., Grambow D., Muzik O., Mosca L., Rubenfire M., Schweiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation. 90:1994;808-817.
2. Treasure C.B., Klein J.L., Vita J.A., et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation. 87:1993;86-93.
3. Leschke M., Schoebel F.-C., Vogt M., et al. Reduced peripheral and coronary vasomotion in systemic hypertension. Eur Heart J. 13:(Suppl D):1992;96-99.
4. Antony I., Nitenberg A., Foult J.-M., Aptecar E. Coronary vasodilator reserve in untreated and treated hypertensive patients with and without left ventricular hypertrophy. J Am Coll Cardiol. 22:1993;514-520.
5. Strauer B.E., Vogt M., Motz W. ACE-inhibitors and coronary microcirculation. Basic Res Cardiol. 88:(Suppl 1):1993;97-106.
6. Vogt M., Motz W., Strauer B.E. Coronary hemodynamics in hypertensive heart disease. Eur Heart J. 13:(Suppl D):1992;44-49.
7. Brush J.E., Faxon D.P., Salmon S., Jakobs A.K., Ryan T.J. Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. J Am Coll Cardiol. 19:1992;809-815.
8. Egashira K., Suzuki S., Hirooka Y., et al. Impaired endothelium-dependent vasodilatation of large epicardial and resistance coronary arteries in patients with essential hypertension. Hypertension. 25:1995;201-206.
9. Mozt W., Strauer B.E. Improvement of coronary flow reserve after long-term therapy with enalapril. Hypertension. 27:1996;1031-1038.
10. Brush J.E., Canon R.O., Schenke W.H., et al. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med. 319:1988;1302-1307.
11. Kozàkovà M., Palombo C., Pratali L., Pittella G., Galetta F., L'Abbate A. Mechanisms of coronary flow reserve impairment in human hypertension. Hypertension. 29:1997;551-559.
12. Parodi O., Neglia D., Sambuceti G., Marabotti C., Palombo C., Donato L. Regional myocardial blood flow and coronary reserve in hypertensive patients. The effect of therapy. Drugs. 44:(Suppl 1):1992;48-55.
13. Frielingsdorf J., Seiler C., Kaufmann P., Vassalli G., Suter T., Hess O. Normalization of abnormal coronary vasomotion by calcium antagonist in patients with hypertension. Circulation. 93:1996;1380-1387.
14. Bergman S.R. Clinical applications of myocardial perfusion assessments made with oxygen-15 water and positron emission tomography. Cardiology. 88:1997;71-79.
15. Uren N.G., Melin J.A., DeBruyne B., Wijns W., Baudhuin T., Camici P.G. Relation between myocardial blood flow and the severity of coronary artery stenosis. N Engl J Med. 330:1994;1782-1788.
16. Pitkänen O.-P., Raitakari O.T., Niinikoski H., et al. Coronary flow reserve is impaired in young men with familial hypercholesterolemia. J Am Coll Cardiol. 28:1996;1705-1711.
17. Pitkänen O.-P., Raitakari O.T., Rönnemaa T., et al. Influence of cardiovascular risk status on coronary flow reserve in healthy young men. Am J Cardiol. 79:1997;1690-1692.
18. Lapinleimu H., Viikari J., Jokinen E., et al. A prospective randomized trial in 1062 infants of a reduced saturated fat and cholesterol diet. Lancet. 345:1995;471-476.
19. Summary of 1993 World Health Organisation-International Society of Hypertension guidelines for the management of mild hypertension. BMJ. 307:1993;1541-1546.
20. Clark J., Crouzel C., Meyer G., Strijckmans K. Current methodology for oxygen-15 production for clinical use. Appl Radiat Isot. 38:1987;597-600.
21. Crouzel C., Clark J., Brihaye C., et al. Radiochemistry automation for PET. Stöcklin G., Pike V. Radiopharmaceuticals for Positron Emission Tomography. 1993;45-90 Kluwer Academic, Dordrecht, The Netherlands.
22. 15O and dynamic positron-emission tomography:strategy for quantification in relation to the partial-volume effect. Circulation. 78:1988;104-115.
23. Iida H., Takahashi A., Tamura Y., Ono Y., Lammertsma A. Myocardial blood flow comparison of oxygen-15-water bolus injection, slow infusion and oxygen-15-carbon dioxide slow inhalation . J Nucl Med. 36:1995;78-85.
24. Iida H., Rhodes C.G., de Silva R., et al. Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. J Nucl Med. 33:1992;1669-1677.
25. Devereux R.B., Alonso D.R., Lutas E.M., et al. Echocardiographic assessment of left ventricular hypertrophy comparison to necropsy findings . Am J Cardiol. 57:1986;450-458.
26. Wilson J.R., Reichek N., Hirshfeld J., Keller C.A. Noninvasive assessment of load reduction in patients with asymptomatic aortic regurgitation. Am J Med. 68:1980;664-673.
27. O'Brien E., Mee F., Atkins N., O'Malley K. Accuracy of the Novacor Diasys 200 determined by the British Hypertension Society Protocol. J Hypertens. 9:(Suppl 5):1991;S9-S15.
28. Kadish A., Little R., Sternberg J. A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem. 14:1968;116-131.
29. Viikari J. Precipitation of plasma lipoproteins by PEG-6000 and its evaluation with electrophoresis and ultracentrifugation. Scand J Clin Lab Invest. 36:1976;265-268.
30. Friedewald W.T., Levy R., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
31. Crowder M.J., Hand D.J. Analysis of Repeated Measures. 1990;Chapman and Hall, London.
32. Wilson R.F., Wyche K., Christensen B.V., Zimmer S., Laxson D.D. Effects of adenosine on human coronary arterial circulation. Circulation. 82:1990;1595-1606.
33. Rubanyi G., Romero J., Vanhoutte P. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol. 250:1986;H1145-H1149.
34. Lupi A., Buffon A., Finocchiaro M.L., Conti E., Maseri A., Crea F. Mechanism of adenosine-induced epicardial coronary artery dilatation. Eur Heart J. 18:1997;614-617.
35. Leipert B., Becker B.F., Gerlach E. Different endothelial mechanisms involved in coronary responses to known vasodilatators. Am J Physiol. 262:1992;H1676-H1683.
36. Mayhan W.G. Endothelium-dependent responses of cerebral arterioles to adenosine 5′-diphosphate. J Vasc Res. 29:1992;353-358.
37. Uren N.G., Marraccini P., Gistri R., deSilva R., Camici P. Altered coronary vasodilator reserve and metabolism in myocardium subtended by normal arteries in patients with coronary artery disease. J Am Coll Cardiol. 22:1993;650-658.
38. Fujii K., Tominaga M., Ohmori S., et al. Decreased endothelium-dependent hyperpolarization to acetylcholine in smooth muscle of the mesenteric artery of spontaneus hypertensive rats. Circ Res. 70:1992;660-669.
39. Lüscher T.F., Vanhoutte P.M. Endothelium-dependent contractions to acetylcholine in the aorta of spontaneously hypertensive rats. Hypertension. 8:1990;344-348.
40. Auch-Schwelk W., Katusic Z.S., Vanhoutte P.M. Nitric oxide inactivates endothelium-derived contracting factor in the rat aorta. Hypertension. 19:1992;442-445.
41. Forte P., Copland M., Smith L.M., Milne E., Sutherland J., Benjamin N. Basal nitric oxide synthesis in essential hypertension. Lancet. 349:1997;837-842.
42. Schwartzkopff B., Motz W., Frenzel H., Vogt M., Knauer S., Strauer B.E. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation. 88:1993;993-1003.
43. Van Hoeven K.H., Factor S. Endomyocardial biopsy diagnosis of small vessel disease a clinicopathologic study . Int J Cardiol. 26:1990;103-110.
44. Marcus M.L., Koyanagi S., Harrison D.G., Doty D.B., Hiratzka L.F., Eastham C.L. Abnormalities in the coronary circulation that occur as a consequence of cardiac hypertrophy. Am J Med. 75:1983;62-66.
45. Cailar G., Ribstein J., Mimran A. Left ventricular contractility and insulin resistance in essential hypertension. Blood Pressure. 4:1995;23-31.
46. Lutas E.M., Devereux R.B., Reis G., et al. Increased cardiac performance in mild essential hypertension. Hypertension. 7:1985;979-988.
47. Hartford M., Wikstrand J.C.M., Wallentin I., Ljungman S.M.G., Berglund G.L. Left ventricular wall stress and systolic function in untreated primary hypertension. Hypertension. 7:1985;97-104.
48. De Simone G., Di Lorenzo L., Constantino G., Moccia D., Buonissiomo S., De Divitiis. Supernormal contractility in primary hypertension without left ventricular hypertrophy. Hypertension. 11:1988;457-463.